Top Biodefense Companies

Global Biodefense Market size was valued at USD 15.29 Billion in 2024 and is poised to grow from USD 16.24 Billion in 2025 to USD 26.27 Billion by 2033, growing at a CAGR of 6.2% during the forecast period (2026–2033).

Key vendors in the Biodefense Market include Bavarian Nordic, Emergent BioSolutions, SIGA Technologies, Siga Technologies, Johnson & Johnson, Pfizer, Sanofi, Merck & Co., Inc., Elusys Therapeutics, and BioNTech. These companies are focusing on vaccines, therapeutics, diagnostics, and preparedness solutions to address biological threats and strengthen national biodefense capabilities.

The key driver of the Biodefense Market is the increasing threat of biological warfare, bioterrorism, and emerging infectious diseases. Rising government investments in national security, pandemic preparedness, vaccine development, advanced diagnostics, and stockpiling of medical countermeasures are further accelerating market growth.

The key market trend in the Biodefense Market is the increasing adoption of advanced, rapid-response technologies for biological threat detection and preparedness. Governments and defense organizations are investing in next-generation diagnostics, genomic surveillance, AI-enabled threat detection, and faster vaccine and therapeutic development to strengthen biodefense capabilities.

North America accounted for the largest share in the Biodefense Market, supported by substantial government funding for biological threat preparedness, advanced healthcare and defense infrastructure, and the presence of leading vaccine, pharmaceutical, diagnostics, and biodefense companies. The United States' focus on national security, pandemic preparedness, and medical countermeasure stockpiling further strengthens regional market leadership.